Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
106.00    4.00 (3.92%)
Bid:
103.80
Ask:
105.20
Spread: 1.40 (1.349%)
Market Cap: £644.68m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Dividend Declaration

5 Jul 2016 18:33

BACIT LIMITED - Dividend Declaration

BACIT LIMITED - Dividend Declaration

PR Newswire

London, July 5

BACIT Limited (the "Company")

(a closed-ended collective investment scheme established as a company with limited liability under the laws of Guernsey with registered number 55514)

2016 Dividend5 July 2016

The Board of the Company is pleased to announce a dividend equivalent to 2.20 pence per ordinary share for the year ended 31 March 2016 (the “2016 Dividend”). The 2016 Dividend will be paid on 19 August 2016 to holders of ordinary shares recorded on the register as at the close of business on 15 July 2016.

The Board has determined that the 2016 Dividend will be paid to the Qualifying Shareholders (as defined below) in the form of new ordinary shares unless those shareholders elect to receive the dividend in cash instead. The number of new shares that each Qualifying Shareholder will receive in payment of the 2016 Dividend will be determined by multiplying the number of existing shares held by the shareholder on the record date by the cash equivalent amount of the 2016 Dividend per share and dividing the resulting number by the net asset value per share of the Company as at 30 June 2016, and then rounding the result down to the nearest whole number. Fractions of new shares will not be issued and cash that otherwise would have been applied by the Company in paying up those fractions will be retained by the Company.

A “Qualifying Shareholder” is a shareholder who is not located in, or with a registered address in, or a citizen of any of the United States, Australia, Canada, Japan, South Africa or any other jurisdiction in respect of which the offer of new shares would or may be unlawful.

Shareholders who are not Qualifying Shareholders will receive the 2016 Dividend in cash. In addition, Qualifying Shareholders can elect to receive the 2016 Dividend in cash. A circular and form of election will be sent to shareholders during the week commencing 11 July 2016. Qualifying Shareholders who wish to receive the 2016 Dividend in cash should complete and return the form of election by 5.00pm on 3 August 2016.

Timetable:

Posting of Circular and Forms of ElectionExpected during the week commencing 11 July 2016
Shares quoted ex-dividend14 July 2016
Record date for dividend15 July 2016
Announcement of the 30 June 2016 NAVExpected during the week commencing 25 July 2016
Final date for receipt by the Receiving Agent of forms of election by Qualifying Shareholders who wish to receive cash5 p.m. on 3 August 2016
Dividend payment date19 August 2016
Shares to be issued and cash to be paid to shareholders who have opted for the cash dividend19 August 2016

In compliance with LR 9.6.1, copies of the following documents will be submitted to the National Storage Mechanism at the same time as they are issued and will be available for inspection at www.hemscott.com/nsm.do:

1.2016 Dividend Circular

2.Form of election

Enquiries:

Company website: www.bacitltd.com

Northern Trust International Fund Administration Services (Guernsey) Limited Martin Bourgaize

+44 (0) 1481 745819

meb16@ntrs.com

Page 2

Date   Source Headline
30th Jun 20207:00 amRNSFreeline announces additional financing plans
30th Jun 20207:00 amRNSFreeline expands Series C financing to $120million
25th Jun 202012:38 pmRNSAnnual Financial Report
18th Jun 202012:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSKemal Malik Appointed as Non-Executive Director
12th Jun 20207:36 amRNSAutolus AUTO1 and AUTO3 data at EHA
11th Jun 20207:00 amRNSFinal Results
29th May 202012:49 pmRNSAutolus presents additional data on AUTO3 in DLBCL
29th May 20207:05 amRNSFirst patient dosed in Achilles’ melanoma study
20th May 20209:24 amRNSNotice of Results
7th May 202012:15 pmRNSAutolus reports Q1 2020 Financial Results
23rd Apr 20207:00 amRNSNew commitment to SwanBio
16th Apr 202012:10 pmRNSAutolus announces acceptance of IND application
31st Mar 20201:26 pmRNSDirector/PDMR Shareholding
26th Mar 20209:41 amRNSStandard form for notification of major holdings
23rd Mar 20207:00 amRNSBusiness Update
20th Mar 20204:44 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20201:53 pmRNSDirector/PDMR Shareholding
5th Mar 202011:14 amRNSDirector/PDMR Shareholding
3rd Mar 202012:29 pmRNSAutolus reports Q4 2019 Financial Results
12th Feb 20202:00 pmRNSFreeline presents clinical data at WORLDSymposium
7th Feb 20201:24 pmRNSFreeline publishes further data for FLT180a
4th Feb 20207:00 amRNSQuarterly Update
30th Jan 202012:08 pmRNSAutolus announces additional data in AUTO3 at EHA
23rd Jan 20207:00 amRNSAutolus announces pricing of public offering
21st Jan 202012:01 pmRNSFreeline to present further FLT180a data at EAHAD
21st Jan 20208:45 amRNSNotice of Capital Markets Day
19th Dec 20197:00 amRNSSyncona makes further $80m commitment to Freeline
9th Dec 20197:00 amRNSAutolus announces new data at ASH Annual Meeting
9th Dec 20197:00 amRNSAutolus announces new data in AUTO3 at ASH
21st Nov 20197:00 amRNSSyncona leads £32 million financing in Azeria
21st Nov 20197:00 amRNSInterim Results
11th Nov 20199:00 amRNSNotice of Results
7th Nov 201912:32 pmRNSAutolus reports Q3 2019 Financial Results
6th Nov 20192:20 pmRNSAutolus to Present New Data at the ASH Meeting
6th Nov 20192:13 pmRNSFreeline presents pre-clinical data at ASH meeting
3rd Sep 20197:00 amRNSSyncona cornerstones £100m financing in Achilles
3rd Sep 20197:00 amRNSSyncona makes £48 million commitment to Gyroscope
12th Aug 20197:00 amRNSQuarterly Update
8th Aug 201912:59 pmRNSAutolus reports Q2 2019 Financial Results
1st Aug 20197:00 amRNSCompletion of sale of Blue Earth Diagnostics
31st Jul 201912:24 pmRNSTotal Voting Rights
30th Jul 201911:55 amRNSResult of AGM
18th Jul 20193:51 pmRNSIssue of shares per 2019 dividend & PDMR dealings
11th Jul 201911:21 amRNSIssue of shares pursuant to LTIP and PDMR dealings
8th Jul 20197:00 amRNSFreeline provides 12 month Haemophilia B data
28th Jun 201912:33 pmRNS2019 Dividend Scrip Reference Price
27th Jun 201911:44 amRNSPublication of Annual Report and Notice of AGM
27th Jun 20197:00 amRNSSale of Blue Earth Diagnostics to Bracco Imaging

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.